In these various murine models, RhoA-G17V overexpression in T cells promoted TFH proliferation/expansion (43, 44) and the concomitant expression in the setting of hematopoietic TET2 deficiency led to the development of TFH lymphomas with varying penetrance (43–45). Here, TET2 is linked to lymphoma.